Health Care & Life Sciences » Pharmaceuticals | Zhejiang Jolly Pharmaceutical Co. Ltd.

Zhejiang Jolly Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
413,149.80
508,239.50
664,268.20
830,355.40
784,520.00
720,787.40
Cost of Goods Sold (COGS) incl. D&A
61,304.50
96,974.30
218,349.80
350,831.40
365,709.70
290,909.80
Gross Income
351,845.30
411,265.10
445,918.50
479,524.10
418,810.30
429,877.50
SG&A Expense
279,205.80
305,248.10
355,296.30
411,560.30
392,479.20
424,173.70
EBIT
69,822.00
102,883.30
86,496.70
108,713.00
24,485.20
37,874.90
Unusual Expense
-
-
-
124.90
-
8,290.60
Non Operating Income/Expense
1,072.20
425.90
1,911.40
6,393.30
47,891.80
22,462.30
Interest Expense
8,983.30
9,426.20
11,772.60
21,434.00
17,715.50
24,165.50
Pretax Income
90,369.20
120,493.00
105,441.30
95,110.20
61,419.70
31,836.10
Income Tax
9,371.70
13,735.70
11,810.60
13,137.30
8,243.10
5,633.40
Equity in Affiliates
-
-
5.60
-
-
16.30
Consolidated Net Income
80,997.50
106,757.30
93,636.40
81,973.00
53,176.50
26,186.40
Net Income
80,997.50
103,184.20
84,773.00
72,020.40
45,140.30
20,751.80
Net Income After Extraordinaries
80,997.50
103,184.20
84,773.00
72,020.40
45,140.30
20,751.80
Net Income Available to Common
80,997.50
103,184.20
84,773.00
72,020.40
45,140.30
20,751.80
EPS (Basic)
0.15
0.19
0.15
0.12
0.07
0.03
Basic Shares Outstanding
538,560.80
531,555.30
565,153.30
608,624.80
608,624.80
608,624.80
EPS (Diluted)
0.15
0.19
0.15
0.12
0.07
0.03
Diluted Shares Outstanding
538,560.80
531,555.30
565,153.30
608,624.80
608,624.80
608,624.80
EBITDA
90,508.20
128,246.90
118,442.00
146,237.50
65,835.10
83,304.70
Other Operating Expense
2,817.50
3,133.70
4,125.40
40,749.20
1,846.00
32,171.10
Non-Operating Interest Income
8,593.90
5,773.20
5,120.60
14,349.40
6,458.20
2,500.20
Minority Interest Expense
-
3,573.10
8,863.40
9,952.50
8,036.30
5,434.70

About Zhejiang Jolly Pharmaceutical Co.

View Profile
Address
No. 388 Zhiyuan North Road
Huzhou Zhejiang 313200
China
Employees -
Website -
Updated 07/08/2019
Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research & development, production and distribution of pharmaceuticals as well as Chinese herbal medicines. Its products include wuling powder, wuling capsule, linglianhua particle, clindamycin phosphate injection, doxapram injection, pefloxacin mesylate injection, azithromycin injection and sodium nitroprusside injection. The company was founded on January 28, 2000 and is headquartered Huzhou, China.